Indications and limitations of afamelanotide for treating vitiligo-reply

JAMA Dermatol. 2015 Mar;151(3):350. doi: 10.1001/jamadermatol.2014.4951.

Authors

Henry W Lim¹, Pearl E Grimes², Mark Lebwohl³

Affiliations

¹ Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
² Vitiligo and Pigmentation Institute of Southern California, Los Angeles.
³ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 25607828
DOI: 10.1001/jamadermatol.2014.4951

No abstract available

Publication types

Comment

MeSH terms

Female
Humans
Male
Ultraviolet Therapy / methods*
Vitiligo / therapy*
alpha-MSH / analogs & derivatives*

Substances

alpha-MSH